ArticleAntioxidants (Basel, Switzerland)2026
Thiourea-Based H
Angela Corvino, Valentina Citi, Antonia Scognamiglio, Alma Martelli, Vincenzo Calderone, Giulia Neggiani, Carmela Fimognari, Ferdinando Fiorino, Elisa Magli, Rosa Sparaco and 3 more
Abstract read
In one paragraphArticle in Antioxidants (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from itWhat it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
13 authors.
Angela CorvinoDepartment of Pharmacy, School of Medicine, University of Naples Federico II, Via D. Montesano, 49, 80131 Naples, Italy.ORCID 0000-0002-0617-156X Valentina CitiDepartment of Pharmacy, University of Pisa, Via Bonanno 6, 56125 Pisa, Italy.
Antonia ScognamiglioDepartment of Pharmacy, School of Medicine, University of Naples Federico II, Via D. Montesano, 49, 80131 Naples, Italy.ORCID 0000-0002-4282-2788 Vincenzo CalderoneDepartment of Pharmacy, University of Pisa, Via Bonanno 6, 56125 Pisa, Italy.
Giulia NeggianiDepartment for Life Quality Studies, Alma Mater Studiorum-Università di Bologna, Corso d'Augusto 237, 47921 Rimini, Italy.ORCID 0009-0007-8836-8713 Carmela FimognariDepartment for Life Quality Studies, Alma Mater Studiorum-Università di Bologna, Corso d'Augusto 237, 47921 Rimini, Italy.ORCID 0000-0002-2461-8214 Ferdinando FiorinoDepartment of Pharmacy, School of Medicine, University of Naples Federico II, Via D. Montesano, 49, 80131 Naples, Italy.ORCID 0000-0001-7357-5751 Elisa MagliDepartment of Public Health, School of Medicine, University of Naples Federico II, Via Panzini, 5, 80131 Naples, Italy.ORCID 0000-0002-9930-9467 Rosa SparacoDepartment of Pharmacy, School of Medicine, University of Naples Federico II, Via D. Montesano, 49, 80131 Naples, Italy.ORCID 0009-0003-4221-5560 Vincenzo SantagadaDepartment of Pharmacy, School of Medicine, University of Naples Federico II, Via D. Montesano, 49, 80131 Naples, Italy.
Giuseppe CaliendoDepartment of Pharmacy, School of Medicine, University of Naples Federico II, Via D. Montesano, 49, 80131 Naples, Italy.
Beatrice SeverinoDepartment of Pharmacy, School of Medicine, University of Naples Federico II, Via D. Montesano, 49, 80131 Naples, Italy.ORCID 0000-0002-3887-8869 Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
Multitarget hybrid molecules are a promising strategy for treating complex neurodegenerative disorders such as Parkinson's disease (PD), where dopaminergic dysfunction, oxidative stress, neuroinflammation, and cellular senescence coexist and drive disease progression. Here, we developed pramipexole-derived hydrogen sulfide (H
Indexed as
antioxidant compoundsH2S-releasing hybridsmultitarget agentsneuroprotective agentsParkinson’s diseases (PD)pramipexole derivativesreactive oxygen species (ROS)thioureas
Identifiers
PMID42193249
PMCPMC13203430
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390